Drug Trial Radar · NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,196
Planned (sponsor's estimate)
Start
Oct 20, 2025
Primary completion
Apr 2, 2029
Study completion Jun 4, 2029
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Sep 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Depemokimab is being developed as a treatment for individuals with moderate to severe Chronic Obstructive Pulmonary Disorder (COPD). The aim of this study is to assess the efficacy and safety of early initiation of depemokimab as an add-on medicine in participants with moderate to severe COPD with type 2 inflammation.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
DepemokimabDrug
Depemokimab will be administered.
PlaceboDrug
Matching placebo will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Moderate/Severe ExacerbationsTime frame: From Baseline Up to Week 156
Locations
293 sites in 25 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Sheffield, Alabama · Recruiting
GSK Investigational Site
Tucson, Arizona · Recruiting
GSK Investigational Site
Escondido, California · Recruiting
GSK Investigational Site
Long Beach, California · Recruiting
GSK Investigational Site
Newport Beach, California · Recruiting
GSK Investigational Site
San Jose, California · Recruiting
GSK Investigational Site
Lakewood, Colorado · Recruiting
GSK Investigational Site
Altamonte Springs, Florida · Recruiting
GSK Investigational Site
Brandon, Florida · Recruiting
GSK Investigational Site
Crystal River, Florida · Recruiting
GSK Investigational Site
Doral, Florida · Recruiting
GSK Investigational Site
Greenacres City, Florida · Recruiting
GSK Investigational Site
Hialeah, Florida · Recruiting
GSK Investigational Site
Hialeah, Florida · Recruiting
GSK Investigational Site
Hollywood, Florida · Recruiting
GSK Investigational Site
Loxahatchee Groves, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami Lakes, Florida · Recruiting
GSK Investigational Site
Miami Lakes, Florida · Recruiting
GSK Investigational Site
Naples, Florida · Recruiting
GSK Investigational Site
Orlando, Florida · Recruiting
GSK Investigational Site
Tampa, Florida · Recruiting
GSK Investigational Site
Adairsville, Georgia · Recruiting
GSK Investigational Site
Cordele, Georgia · Recruiting
GSK Investigational Site
Dunwoody, Georgia · Recruiting
GSK Investigational Site
Boise, Idaho · Recruiting
GSK Investigational Site
Peoria, Illinois · Recruiting
GSK Investigational Site
Indianapolis, Indiana · Recruiting
GSK Investigational Site
Bowling Green, Kentucky · Recruiting
GSK Investigational Site
Baton Rouge, Louisiana · Recruiting
GSK Investigational Site
Lake Charles, Louisiana · Recruiting
GSK Investigational Site
Metairie, Louisiana · Recruiting
GSK Investigational Site
Shreveport, Louisiana · Recruiting
GSK Investigational Site
Bangor, Maine · Recruiting
GSK Investigational Site
Fall River, Massachusetts · Recruiting
GSK Investigational Site
Allen Park, Michigan · Recruiting
GSK Investigational Site
Clarkston, Michigan · Recruiting
Showing 40 of 293 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.